Banks made it through the latest round of stress testing relatively unscathed, setting investors up for news of payouts. » Read More
Russia's defence ministry said on Wednesday that a poisonous gas contamination in the Syrian town of Khan Sheikhoun was the result of gas leaking from a rebel chemical weapons depot.
At least 58 people, including 11 children, died in the attack, and the death toll could rise, according to NBC News.
China, the world's biggest coking coal importer, is scrambling to cover Australian supply disruptions.
U.S. regulators have given tentative approval to a Chinese conglomerate's proposed $43 billion acquisition of Swiss agribusiness giant Syngenta.
Jim Cramer says that in reality, "valuation is in the eye of the beholder."
A senior McAfee executive explained to CNBC how McAfee, as a standalone security company, can tackle cybersecurity and risk.
A number of firms traded in China could see a share bump come Wednesday following the announcement of a new special economic zone.
GSK is voluntarily recalling over 593,000 Ventolin asthma inhalers from US hospitals, pharmacies, retailers and wholesalers due to a defect.
Venezuelan security forces quelled masked protesters with tear gas, water cannons and pepper spray in Caracas on Tuesday after blocking an opposition rally against socialist President Nicolas Maduro.
Oliver Pursche explains why he's still investing in this market.
Emerging markets funds could see further upside after logging a stellar first quarter, according to traders.
Opposition to border adjustment threatens to delay or trip up efforts to pass tax reform.
Amazon is paying around $50 million for the 10 games it will show next fall, according to a person familiar with the deal.
Payless ShoeSource adds its name to a growing list of chains that have struggled to compete against online and off-price retailers.
Amazon is keeping the wraps on its physical grocery experiments. But its high-tech brick-and-mortar bookstores could give hints.
U.S. President Donald Trump will discuss how to rein in North Korea with Chinese President Xi Jinping later this week, a senior White House official said.
Jim Cramer gave a dose of wisdom on a biotech company that is taking on the hemophilia space.
Since the Fed raised rates on March 15, the 10-year yield has done nothing but go down, so it may be worth seeing what the charts have to say.
A senior U.S. general warned about North Korean missile advances, calling it "very challenging" in remarks to a Senate panel.
CNBC's Bob Pisani chats with iShares Fixed Income Strategist Karen Schenone about why the yield curve is flattening in a rising rates environment.